OTC · Financial Statements
GB Sciences, Inc. (GBLX) Financial Statements
$0.00
OTC: GBLX
Market Cap $122121
Overview Financials Dividend GB Sciences, Inc. most recently reported annual revenue of $0, net profit of $-1.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2019 2020 2021 2022 2023 Revenue $3.0M $0 $0 $0 $0 Operating Profit $-12.0M $-2.0M $-2.0M $-2.0M $-1.0M Net Profit $-12.0M $-4.0M $-1.0M $-4.0M $-1.0M EPS $-0.04 $-0.01 $0.00 $-0.01 $0.00 Op Margin -384.8% — — — —
Balance Sheet (USD)
Metric 2019 2020 2021 2022 2023 Total Assets $14.0M $11.0M $3.0M $0 $0 Total Liabilities $14.0M $12.0M $4.0M $5.0M $5.0M Cash $0 $1.0M $0 $0 $0 Borrowings $9.0M $4.0M $1.0M $1.0M $2.0M
Cash Flow (USD)
Metric 2019 2020 2021 2022 2023 Operating Cash Flow $-4.0M $-2.0M $-2.0M $-2.0M $-1.0M Investing Cash Flow $-1.0M $4.0M $1.0M $0 $0 Financing Cash Flow $1.0M $0 $0 $0 $0 Net Cash Flow $0 $1.0M $-1.0M $0 $0 Free Cash Flow $-5.0M $-2.0M $-2.0M $-2.0M $-1.0M
Valuation & Return Ratios
Metric Value PEG Ratio 0.00 EV / EBITDA -1.32 FCF Yield -818.86% Quick Ratio 0.02 Interest Coverage -6.49 Return 1Y — Return 3Y — Return 5Y —
Screens featuring this stock